EZH2 expression was significantly higher in the UAMS molecularly defined PR subgroup,13 which is characterised by the overexpression of cancer-testis antigens, cell cycle and proliferation-related genes (Figure 1c), and was significantly higher in GEP70 high-risk patients (Figure 1d). This evidence concerns the gene EZH2 and cancer.